Loading…

Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel

[Display omitted] •A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers. A novel biotin and arginine modified hydroxypro...

Full description

Saved in:
Bibliographic Details
Published in:Carbohydrate polymers 2019-07, Vol.216, p.129-139
Main Authors: Yan, Caixia, Liang, Na, Li, Qiang, Yan, Pengfei, Sun, Shaoping
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803
cites cdi_FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803
container_end_page 139
container_issue
container_start_page 129
container_title Carbohydrate polymers
container_volume 216
creator Yan, Caixia
Liang, Na
Li, Qiang
Yan, Pengfei
Sun, Shaoping
description [Display omitted] •A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers. A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin (biotin-Arg(pbf)-HP-β-CD) was successfully synthesized. The hydroxyl groups of HP-β-CD on the primary faces were coupled with carboxyl groups of biotin using arginine as the functional spacer. Using biotin-Arg(pbf)-HP-β-CD as the carrier, paclitaxel (PTX)-loaded nanoparticles were developed by modified emulsion solvent evaporation method. The optimized PTX-loaded biotin-Arg(pbf)-HP-β-CD nanoparticles had a mean diameter of 121.9 nm and zeta potential of -57.7 mV. Transmission electron microscopy (TEM) observation revealed that the nanoparticles were spherical in shape. XRD spectra confirmed the successful encapsulation of PTX. Moreover, in vitro and in vivo evaluations were performed to demonstrate the superior antitumor activity of the PTX-loaded nanoparticles. The cellular uptake study demonstrated the biotin receptor-mediated endocytosis of biotin-Arg(pbf)-HP-β-CD nanoparticles and the increase of cellular uptake by introduction of biotin and arginine. It can be concluded that the biotin-Arg(pbf)-HP-β-CD nanoparticles are efficient tumor-targeting drug delivery systems for PTX.
doi_str_mv 10.1016/j.carbpol.2019.04.024
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2229236868</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0144861719304084</els_id><sourcerecordid>2229236868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803</originalsourceid><addsrcrecordid>eNqFkEGO1DAQRS0EYnoGjgDykk1C2XEcZ4VgBAzSSGxgbTl2ZXDLsYOdbnWuxUE4Exl1w5ba1Ob9-qpHyCsGNQMm3-5ra_Iwp1BzYH0NogYunpAdU11fsUaIp2QHTIhKSdZdketS9rCNZPCcXDUMRAei35HjB58WH6mJjpr84KOPSKfk_OjR0R-ry-m0zjnNa6h-_6rsakNyeFrylokmptnkxduAhZpCYzpioC4fHqjD4I-YV1rWsuBU6JgynY0NfjEnDC_Is9GEgi8v-4Z8__Tx2-1ddf_185fb9_eVbWS7VH1rcQTHWimHphdC2HEEYaQYnGs65IZLbtumlbYfFDcd9GwwjDnLFSiloLkhb853txd-HrAsevLFYggmYjoUzTnveSOVVBvanlGbUykZRz1nP5m8agb6Ubne64ty_ahcg9Cb8i33-lJxGCZ0_1J_HW_AuzOA26NHj1kX6zFadD6jXbRL_j8VfwCmE5h_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229236868</pqid></control><display><type>article</type><title>Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel</title><source>Elsevier</source><creator>Yan, Caixia ; Liang, Na ; Li, Qiang ; Yan, Pengfei ; Sun, Shaoping</creator><creatorcontrib>Yan, Caixia ; Liang, Na ; Li, Qiang ; Yan, Pengfei ; Sun, Shaoping</creatorcontrib><description>[Display omitted] •A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers. A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin (biotin-Arg(pbf)-HP-β-CD) was successfully synthesized. The hydroxyl groups of HP-β-CD on the primary faces were coupled with carboxyl groups of biotin using arginine as the functional spacer. Using biotin-Arg(pbf)-HP-β-CD as the carrier, paclitaxel (PTX)-loaded nanoparticles were developed by modified emulsion solvent evaporation method. The optimized PTX-loaded biotin-Arg(pbf)-HP-β-CD nanoparticles had a mean diameter of 121.9 nm and zeta potential of -57.7 mV. Transmission electron microscopy (TEM) observation revealed that the nanoparticles were spherical in shape. XRD spectra confirmed the successful encapsulation of PTX. Moreover, in vitro and in vivo evaluations were performed to demonstrate the superior antitumor activity of the PTX-loaded nanoparticles. The cellular uptake study demonstrated the biotin receptor-mediated endocytosis of biotin-Arg(pbf)-HP-β-CD nanoparticles and the increase of cellular uptake by introduction of biotin and arginine. It can be concluded that the biotin-Arg(pbf)-HP-β-CD nanoparticles are efficient tumor-targeting drug delivery systems for PTX.</description><identifier>ISSN: 0144-8617</identifier><identifier>EISSN: 1879-1344</identifier><identifier>DOI: 10.1016/j.carbpol.2019.04.024</identifier><identifier>PMID: 31047049</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>2-Hydroxypropyl-beta-cyclodextrin - chemical synthesis ; 2-Hydroxypropyl-beta-cyclodextrin - chemistry ; 2-Hydroxypropyl-beta-cyclodextrin - toxicity ; Animals ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Arginine ; Arginine - analogs &amp; derivatives ; Arginine - chemical synthesis ; Arginine - toxicity ; Biotin ; Biotin - analogs &amp; derivatives ; Biotin - chemical synthesis ; Biotin - toxicity ; Carcinoma - drug therapy ; Drug Carriers - chemical synthesis ; Drug Carriers - chemistry ; Drug Carriers - toxicity ; Female ; Humans ; Hydroxypropyl-β-cyclodextrin ; MCF-7 Cells ; Mice ; Nanoparticles ; Nanoparticles - chemistry ; Nanoparticles - toxicity ; Paclitaxel ; Paclitaxel - chemistry ; Paclitaxel - pharmacology ; Paclitaxel - therapeutic use ; Particle Size ; Uterine Cervical Neoplasms - drug therapy ; Xenograft Model Antitumor Assays</subject><ispartof>Carbohydrate polymers, 2019-07, Vol.216, p.129-139</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803</citedby><cites>FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31047049$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yan, Caixia</creatorcontrib><creatorcontrib>Liang, Na</creatorcontrib><creatorcontrib>Li, Qiang</creatorcontrib><creatorcontrib>Yan, Pengfei</creatorcontrib><creatorcontrib>Sun, Shaoping</creatorcontrib><title>Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel</title><title>Carbohydrate polymers</title><addtitle>Carbohydr Polym</addtitle><description>[Display omitted] •A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers. A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin (biotin-Arg(pbf)-HP-β-CD) was successfully synthesized. The hydroxyl groups of HP-β-CD on the primary faces were coupled with carboxyl groups of biotin using arginine as the functional spacer. Using biotin-Arg(pbf)-HP-β-CD as the carrier, paclitaxel (PTX)-loaded nanoparticles were developed by modified emulsion solvent evaporation method. The optimized PTX-loaded biotin-Arg(pbf)-HP-β-CD nanoparticles had a mean diameter of 121.9 nm and zeta potential of -57.7 mV. Transmission electron microscopy (TEM) observation revealed that the nanoparticles were spherical in shape. XRD spectra confirmed the successful encapsulation of PTX. Moreover, in vitro and in vivo evaluations were performed to demonstrate the superior antitumor activity of the PTX-loaded nanoparticles. The cellular uptake study demonstrated the biotin receptor-mediated endocytosis of biotin-Arg(pbf)-HP-β-CD nanoparticles and the increase of cellular uptake by introduction of biotin and arginine. It can be concluded that the biotin-Arg(pbf)-HP-β-CD nanoparticles are efficient tumor-targeting drug delivery systems for PTX.</description><subject>2-Hydroxypropyl-beta-cyclodextrin - chemical synthesis</subject><subject>2-Hydroxypropyl-beta-cyclodextrin - chemistry</subject><subject>2-Hydroxypropyl-beta-cyclodextrin - toxicity</subject><subject>Animals</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Arginine</subject><subject>Arginine - analogs &amp; derivatives</subject><subject>Arginine - chemical synthesis</subject><subject>Arginine - toxicity</subject><subject>Biotin</subject><subject>Biotin - analogs &amp; derivatives</subject><subject>Biotin - chemical synthesis</subject><subject>Biotin - toxicity</subject><subject>Carcinoma - drug therapy</subject><subject>Drug Carriers - chemical synthesis</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Carriers - toxicity</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxypropyl-β-cyclodextrin</subject><subject>MCF-7 Cells</subject><subject>Mice</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Nanoparticles - toxicity</subject><subject>Paclitaxel</subject><subject>Paclitaxel - chemistry</subject><subject>Paclitaxel - pharmacology</subject><subject>Paclitaxel - therapeutic use</subject><subject>Particle Size</subject><subject>Uterine Cervical Neoplasms - drug therapy</subject><subject>Xenograft Model Antitumor Assays</subject><issn>0144-8617</issn><issn>1879-1344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkEGO1DAQRS0EYnoGjgDykk1C2XEcZ4VgBAzSSGxgbTl2ZXDLsYOdbnWuxUE4Exl1w5ba1Ob9-qpHyCsGNQMm3-5ra_Iwp1BzYH0NogYunpAdU11fsUaIp2QHTIhKSdZdketS9rCNZPCcXDUMRAei35HjB58WH6mJjpr84KOPSKfk_OjR0R-ry-m0zjnNa6h-_6rsakNyeFrylokmptnkxduAhZpCYzpioC4fHqjD4I-YV1rWsuBU6JgynY0NfjEnDC_Is9GEgi8v-4Z8__Tx2-1ddf_185fb9_eVbWS7VH1rcQTHWimHphdC2HEEYaQYnGs65IZLbtumlbYfFDcd9GwwjDnLFSiloLkhb853txd-HrAsevLFYggmYjoUzTnveSOVVBvanlGbUykZRz1nP5m8agb6Ubne64ty_ahcg9Cb8i33-lJxGCZ0_1J_HW_AuzOA26NHj1kX6zFadD6jXbRL_j8VfwCmE5h_</recordid><startdate>20190715</startdate><enddate>20190715</enddate><creator>Yan, Caixia</creator><creator>Liang, Na</creator><creator>Li, Qiang</creator><creator>Yan, Pengfei</creator><creator>Sun, Shaoping</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190715</creationdate><title>Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel</title><author>Yan, Caixia ; Liang, Na ; Li, Qiang ; Yan, Pengfei ; Sun, Shaoping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>2-Hydroxypropyl-beta-cyclodextrin - chemical synthesis</topic><topic>2-Hydroxypropyl-beta-cyclodextrin - chemistry</topic><topic>2-Hydroxypropyl-beta-cyclodextrin - toxicity</topic><topic>Animals</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Arginine</topic><topic>Arginine - analogs &amp; derivatives</topic><topic>Arginine - chemical synthesis</topic><topic>Arginine - toxicity</topic><topic>Biotin</topic><topic>Biotin - analogs &amp; derivatives</topic><topic>Biotin - chemical synthesis</topic><topic>Biotin - toxicity</topic><topic>Carcinoma - drug therapy</topic><topic>Drug Carriers - chemical synthesis</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Carriers - toxicity</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxypropyl-β-cyclodextrin</topic><topic>MCF-7 Cells</topic><topic>Mice</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Nanoparticles - toxicity</topic><topic>Paclitaxel</topic><topic>Paclitaxel - chemistry</topic><topic>Paclitaxel - pharmacology</topic><topic>Paclitaxel - therapeutic use</topic><topic>Particle Size</topic><topic>Uterine Cervical Neoplasms - drug therapy</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yan, Caixia</creatorcontrib><creatorcontrib>Liang, Na</creatorcontrib><creatorcontrib>Li, Qiang</creatorcontrib><creatorcontrib>Yan, Pengfei</creatorcontrib><creatorcontrib>Sun, Shaoping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Carbohydrate polymers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yan, Caixia</au><au>Liang, Na</au><au>Li, Qiang</au><au>Yan, Pengfei</au><au>Sun, Shaoping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel</atitle><jtitle>Carbohydrate polymers</jtitle><addtitle>Carbohydr Polym</addtitle><date>2019-07-15</date><risdate>2019</risdate><volume>216</volume><spage>129</spage><epage>139</epage><pages>129-139</pages><issn>0144-8617</issn><eissn>1879-1344</eissn><abstract>[Display omitted] •A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin is synthesized.•Based on this polymer, a paclitaxel-loaded nanoparticles system is developed.•The paclitaxel-loaded nanoparticles are promising drug delivery carriers. A novel biotin and arginine modified hydroxypropyl-β-cyclodextrin (biotin-Arg(pbf)-HP-β-CD) was successfully synthesized. The hydroxyl groups of HP-β-CD on the primary faces were coupled with carboxyl groups of biotin using arginine as the functional spacer. Using biotin-Arg(pbf)-HP-β-CD as the carrier, paclitaxel (PTX)-loaded nanoparticles were developed by modified emulsion solvent evaporation method. The optimized PTX-loaded biotin-Arg(pbf)-HP-β-CD nanoparticles had a mean diameter of 121.9 nm and zeta potential of -57.7 mV. Transmission electron microscopy (TEM) observation revealed that the nanoparticles were spherical in shape. XRD spectra confirmed the successful encapsulation of PTX. Moreover, in vitro and in vivo evaluations were performed to demonstrate the superior antitumor activity of the PTX-loaded nanoparticles. The cellular uptake study demonstrated the biotin receptor-mediated endocytosis of biotin-Arg(pbf)-HP-β-CD nanoparticles and the increase of cellular uptake by introduction of biotin and arginine. It can be concluded that the biotin-Arg(pbf)-HP-β-CD nanoparticles are efficient tumor-targeting drug delivery systems for PTX.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31047049</pmid><doi>10.1016/j.carbpol.2019.04.024</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0144-8617
ispartof Carbohydrate polymers, 2019-07, Vol.216, p.129-139
issn 0144-8617
1879-1344
language eng
recordid cdi_proquest_miscellaneous_2229236868
source Elsevier
subjects 2-Hydroxypropyl-beta-cyclodextrin - chemical synthesis
2-Hydroxypropyl-beta-cyclodextrin - chemistry
2-Hydroxypropyl-beta-cyclodextrin - toxicity
Animals
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Arginine
Arginine - analogs & derivatives
Arginine - chemical synthesis
Arginine - toxicity
Biotin
Biotin - analogs & derivatives
Biotin - chemical synthesis
Biotin - toxicity
Carcinoma - drug therapy
Drug Carriers - chemical synthesis
Drug Carriers - chemistry
Drug Carriers - toxicity
Female
Humans
Hydroxypropyl-β-cyclodextrin
MCF-7 Cells
Mice
Nanoparticles
Nanoparticles - chemistry
Nanoparticles - toxicity
Paclitaxel
Paclitaxel - chemistry
Paclitaxel - pharmacology
Paclitaxel - therapeutic use
Particle Size
Uterine Cervical Neoplasms - drug therapy
Xenograft Model Antitumor Assays
title Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A41%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biotin%20and%20arginine%20modified%20hydroxypropyl-%CE%B2-cyclodextrin%20nanoparticles%20as%20novel%20drug%20delivery%20systems%20for%20paclitaxel&rft.jtitle=Carbohydrate%20polymers&rft.au=Yan,%20Caixia&rft.date=2019-07-15&rft.volume=216&rft.spage=129&rft.epage=139&rft.pages=129-139&rft.issn=0144-8617&rft.eissn=1879-1344&rft_id=info:doi/10.1016/j.carbpol.2019.04.024&rft_dat=%3Cproquest_cross%3E2229236868%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-95cef0d1566b39444cff04a64bdd37e2a262c5356c9b82a7091ba11dc28088803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2229236868&rft_id=info:pmid/31047049&rfr_iscdi=true